India Global Business Staff2020-12-04T12:40:32+00:00August 26th, 2020|Analysis - India Global Business, India Inc Views - India Global Business|
From market to e-market, the ease of delivery and huge discounts in the online pharmacy sector is propelling the country’s e-pharma segment to new highs having added six million new customers since the pandemic struck
India Global Business Staff2020-08-20T03:24:58+00:00August 19th, 2020|India Inc Views - India Global Business, News in Brief|
India's Reliance Industries Ltd has bought a majority stake in online pharmacy Netmeds for 6.2 billion rupees ($83 million), facing up to Amazon.com in the competition for the country's fast-expanding online drug market.
Saloni Shah2020-08-20T13:09:00+00:00August 12th, 2020|India Inc Views - India Global Business, Special Report - India Global Business|
UK pharmaceutical major AstraZeneca’s recent tie-up with the Serum Institute of India is a major step towards the goal of broad and equitable global access to a potential Covid-19 vaccine.
Ishita Mandrekar2020-08-20T13:06:57+00:00August 12th, 2020|Analysis - India Global Business, India Inc Views - India Global Business|
When the world emerges from the Covid-19 crisis there will be a greater need to improve and upgrade healthcare infrastructure. And Indian healthcare companies will have a lot to offer Africa in that respect.
Saloni Shah2020-08-06T12:23:32+00:00August 6th, 2020|India Inc Views - India Global Business, Special Report - India Global Business|
A new manufacturing deal with Mumbai-headquartered global pharma and biotech giant Wockhardt’s Welsh subsidiary reflects yet another booster for the UK’s Covid-19 vaccine access drive.
Saloni Shah2020-08-05T12:33:53+00:00August 5th, 2020|India Inc Views - India Global Business, News in Brief|
Indian Pharma giant Wockhardt has teamed up with the UK government to fill-finish Covid-19 vaccines.
India Global Business Staff2020-08-20T07:59:02+00:00July 30th, 2020|India Inc Views - India Global Business, News in Brief|
Taro Pharmaceutical, a US based subsidiary of Sun Pharma, will acquire 100 per cent stake in the company.
India Global Business Staff2020-08-20T06:41:49+00:00July 6th, 2020|India Inc Views - India Global Business, News in Brief|
KKR will acquire the stake from the founding Mody family at a price of $9.97 per share and make an open offer for an additional 26 percent stake in the company.
India Inc. Staff2020-08-19T05:58:41+00:00July 1st, 2020|Guest Columns - India Global Business, Social Impact Focus - India Global Business|
The top executive of Indian multinational pharmaceutical company, Lupin, shares the various initiatives the company has undertaken to support the frontline healthcare workers in the US during the pandemic.
Saloni Shah2020-06-30T12:33:23+00:00June 30th, 2020|India Inc Views - India Global Business, News in Brief|
The transaction values Piramal Pharma Ltd at $2.775 billion, with an upside component of $360 million.
